Please provide your email address to receive an email when new articles are posted on . More than 25% of patients with gout who use colchicine prophylaxis were on potentially interacting medications.
• Colchicine: While colchicine has successfully treated both acute and chronic gout for ages, clinicians must be judicious about dosing. No one should be dosing patients with acute gout “to the onset ...
Gout flares are commonly treated with colchicine, which can provoke GI side effects, particularly diarrhea. The Acute Gout Flare Receiving Colchicine Evaluation (AGREE) trial investigated the efficacy ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — The use of colchicine for gout flare prevention imparts a “modest” decrease in the risk for knee or ...
Chia-Hsueh Lee, PhD, and Yaxin Dai, PhD, St. Jude Department of Structural Biology obtained ten structures of the human urate transporter URAT1 to uncover the transporter’s mechanism of action and ...
In patients with gout starting allopurinol as a long-term urate-lowering therapy, the prophylactic use of nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with a higher risk for major ...
WASHINGTON — Colchicine does not protect against major cardiovascular adverse events after an acute myocardial infarction, according to a multinational placebo-controlled trial of more than 7000 ...
Nov 27 (Reuters) - Anti-inflammatory colchicine will be tested as a possible COVID-19 treatment in one of the world's biggest trials, the study website posted on Friday, the latest effort to repurpose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results